for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Germany needs 200 million vaccine doses next year as a buffer - ministry paper

BERLIN, June 30 (Reuters) - Germany plans to buy some 204 million doses of COVID-19 vaccine for 2022, far more than the two each needed for its 84 million population, in order to have a comfortable buffer in case of mutations or a need for booster shots.

A health ministry paper seen by Reuters said that the contract the European Union signed with Biontech and Pfizer for their mRNA-type vaccine covered Germany’s needs next year in the best case, but the extra would provide added security.

The paper said at least one other mRNA-type vaccine should be procured, as well as a vaccine using another technology, to help guard against production bottlenecks. (Reporting by Andreas Rinke, writing by Thomas Escritt; editing by Diane Craft)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up